Influenza Market, 2022 - Vaccines, Therapeutics and Diagnostics

News provided by

Apr 25, 2018, 09:45 ET

DUBLIN, April 25, 2018 /PRNewswire/ --

The "The Global Influenza Market" report has been added to ResearchAndMarkets.com's offering.

This report is designed to be a helpful business tool that provides a thorough evaluation of the market for influenza vaccines, therapeutics and diagnostics. The geographic scope of this study is global, with emphasis on U.S. and European data.

The report identifies markets in general segments: Vaccines, Therapeutics and Diagnostics. Each market segment discussion provides detailed information based on product categories, uses of products, forecasts and competitive analyses. Additionally, the study covers some of the most significant issues, trends and market factors.

Report Includes:

25 data tables and 77 additional tables
An overview of the global influenza market
Analyses of global market trends, with data from 2016 and 2017, and projections of compound annual growth rates (CAGRs) through 2022
Identification of segments with high growth potential and their future applications
Explanation of major drivers and regional dynamics of the market and current trends within the industry
Detailed profiles of major vendors in the market, including Alere Inc., MedImmune, LLC, Cepheid Inc., GlaxoSmithKline plc and Qiagen N.V.

Key Topics Covered:

1 Introduction

Influenza Overview
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
Related Reports

2 Summary and Highlights

The Influenza Market: Summary of Major Markets

3 Industry Overview and Background

Overview
History of the Market
Epidemics and Pandemics in History
Virus Mutations
Influenza Types
WHO and CDC Influenza Response
World Health Organization
Centers for Disease Control and Prevention
U.S. Viral Surveillance
FDA's Vaccine and Related Biological Products Advisory Committee and Vaccine Composition
Vaccine Recommendations
Vaccine Effectiveness
Universal Vaccine
Population Demographics and Influenza Incidence/Mortality
Global Demographics
Global Life Expectancy
Influenza Incidence and Mortality
The 2017-2018 Influenza Season (Through January 2018)

4 Global Influenza Vaccine Market

Overview
Current Vaccines
The Global Influenza Vaccine Market
Seasonal versus Pandemic Sales
Regional Market Summary
The U.S. Influenza Vaccine Market
History of Vaccine Manufacturer Participation in the United States
The European Influenza Vaccine Market
Global Competitor Analysis
Influenza Vaccine Developments
Clinical Trials

5 Global Influenza Therapeutics Market

Overview
Current Therapies
Generic Availability
The Global Influenza Therapeutics Market
Seasonal versus Pandemic Sales
Regional Market Summary
The U.S. Influenza Therapeutics Market
The European Influenza Therapeutics Market
Global Competitor Analysis
Influenza Treatment Developments
Clinical Trials

6 Global Influenza Diagnostic Market

Overview
Test Descriptions
Product Descriptions
Laboratory Services
The Global Influenza Diagnostic Market
Regional Market Summary
Global Competitor Analysis

7 Influenza Pandemic Impact

Epidemic/Pandemic Threat
H1N1 Outbreak 2009 (Swine Flu)
Rapid Diagnostics
Pandemic Testing
Seasonal Influenza Tests
Avian Flu
Avian Flu Surveillance
The WHO and Containment for Pandemic Influenza
International Influenza Vaccine Stockpile Orders
Pre-Pandemic Vaccination
Biomedical Advanced Research and Development Authority (BARDA)
Antiviral Resistance
Recreated Viruses
Immaterialized Market Risk
Media Coverage and Vaccinations
Pandemic Preparedness Plans
Infrared Sensors and Thermal Imagers
The United States
Japan
China
Brazil
United Kingdom

8 Patent Review/ New Developments

Overview
Influenza Patent Review by Year
Influenza Patent Review by Country
Influenza Patent Review by Assignee
Massachusetts Institute of Technology (MIT)
Seqirus U.K. Limited
Academia Sinica
Celltrion Inc.
Icahn School of Medicine at Mount Sinai
Shionogi & Co. Ltd.
Vertex Pharmaceuticals Inc.
Xiamen University

9 Analysis of Market Opportunities

Overview of Influenza Market Trends
Total Market Analysis
Regional Market Summary

10 Company Profiles

Alere Inc.
Medimmune/Astrazeneca
Medimmune Inc.
Becton Dickinson And Company
Cepheid
Daiichi Sankyo
Glaxosmithkline Plc
Hologic Inc
Luminex Corp.
Mitsubishi Tanabe Pharma Corp.
Mylan N.V.
Orasure Technologies
Qiagen N.V.
Quidel Corp.
Roche
Sanofi/Sanofi Pasteur
Sekisui Diagnostics Llc
Seqirus

For more information about this report visit https://www.researchandmarkets.com/research/w4hrq6/influenza_market?w=5

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets